Pharmacovigilance is a science of detecting and reporting adverse drug reactions, adverse events, and abnormal laboratory findings. Prior to release into the market, all new medicines/ medical devices must have completed a series of clinical trials with patients. These trials are aimed to establish the safety and efficacy of the…
What is Pharmacovigilance? An apple a day keeps the doctor away. But nothing ever keeps a researcher away. A researcher’s job is the backbone of medical sciences. Clinical research is, therefore, a driving factor for the healthy survival of human beings. It is common knowledge that any drug, prior to…
DIAGNOSTIC TEST FOR COVID-19 The coronavirus COVID -19 is posing major challenges for healthcare systems and medical institutions worldwide. An ability to rapidly diagnose the virus is of invaluable help in curbing its exponential spread in many countries. Bosch’s new, fully automated rapid test for COVID-19 can help medical facilities…
Gastroesophageal reflux disease (GERD) is when food or liquid travels from the stomach back up into the esophagus (the tube from the mouth to the stomach). This partially digested material is usually acidic and can irritate the esophagus, often causing heartburn and other symptoms. Our digestive system is supposed to…
WHAT IS INTELLECTUAL PROPERTY? Intellectual property refers to any; Creations of mind Inventions Literary & artistic works Symbols, names, and images used in commerce. Intellectual property is divided into two categories; Industrial property like patents for inventions, trademarks, industrial designs, and geographical indications. Copyright for literary works, architectural design, and…
EMA During a virtual meeting held on 2nd April 2020, EMA’s human medicines committee (CHMP) gave recommendations on how to use the investigational antiviral medicine, Remdesivir for treating coronavirus disease (COVID-19) in compassionate use programmes in the European Union. Remdesivir has been shown to be active against SARS-CoV-2 and other types of coronavirus (i.e. SARS-CoV and MERS-CoV)…
India has become a hub for clinical trials today after it has made the required regulatory changes that have fast-tracked the growth of clinical research in India, which has the market expecting to grow at a CAGR of approximately 12%. With clinical research being a booming industry, there are lacs…
